• Nutriband CEO Gareth Sheridan appeared on latest Jack Neel Podcast episode to discuss US fentanyl crisis.
• Interview highlighted Nutriband AVERSA abuse-deterrent transdermal technology as a way to reduce abuse, diversion, misuse, and accidental exposure for drugs such as fentanyl.
• Management reiterated lead development focus on an abuse-deterrent fentanyl patch that incorporates AVERSA technology.
• Nutriband said AVERSA technology can be incorporated into any transdermal patch for drugs with abuse potential.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nutriband Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202604220700PRIMZONEFULLFEED9694459) on April 22, 2026, and is solely responsible for the information contained therein.